BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 22, 2007
View Archived Issues
Novartis reports pipeline and business highlights of first quarter
Read More
Therapeutic autophagy by small-molecule enhancers shows promise for neurodegenerative diseases
Read More
Recent Bayer patent describes new treatment option for thrombotic disorders
Read More
Recent Pharmaleads and Pfizer patents disclose novel analgesic agents
Read More
Novel antimalarial agents disclosed in recent patent literature
Read More
Novel arylhydrocarbon receptor antagonist may protect against skin photodamage
Read More
Recent Valeant and Medivir patents report novel agents for HIV infection
Read More
Gene Logic seeks new development paths for Abbott drugs
Read More
Update on Memryte program in Alzheimer's
Read More
Phase I findings on S. aureus vaccine
Read More
ReNeuron forms collaboration to develop c-mycERstem cell expansion technology
Read More
ReAble Therapeutics to acquire Iomed
Read More
FDA Advisory Committee votes in favor of ACAM-2000
Read More
New phase II trial studies DNB-001 for ocular hypertension
Read More
Novartis defends Lotrel patent against Teva generic
Read More
Ortho Biotech Products to return BMP-7 program to Curis
Read More
Ty-800 typhoid vaccine shows clinical potential
Read More
Wex seeks clearance for Canadian study of Tectin
Read More
Sun Pharmaceutical to acquire Taro
Read More
TRO-19622 begins phase II trial in painful diabetic neuropathy
Read More
Towards new additions to the therapeutic armamentarium in psoriasis
Read More
Prous Science publishes new report on tuberculosis
Read More
FDA approves Velcade + Doxil for relapsed/refractory multiple myeloma
Read More
